» Articles » PMID: 38872946

Rehmanniae Radix Preparata Ameliorates Behavioral Deficits and Hippocampal Neurodevelopmental Abnormalities in ADHD Rat Model

Overview
Journal Front Neurosci
Date 2024 Jun 14
PMID 38872946
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Abnormal hippocampal neurodevelopment, particularly in the dentate gyrus region, may be a key mechanism of attention-deficit/hyperactivity disorder (ADHD). In this study, we investigate the effect of the most commonly used Chinese herb for the treatment of ADHD, Rehmanniae Radix Preparata (RRP), on behavior and hippocampal neurodevelopment in spontaneously hypertensive rats (SHR).

Methods: Behavior tests, including Morris water maze (MWM) test, open field test (OFT) and elevated plus maze (EPM) test were performed to assess the effect of RRP on hyperactive and impulsive behavior. Hippocampal neurodevelopment was characterized by transmission electron microscopy, immunofluorescence, Golgi staining and Nissl staining approaches. Regulatory proteins such as Trkb, CDK5, FGF2/FGFR1 were examined by Western blot analysis.

Results: The results showed that RRP could effectively control the impulsive and spontaneous behavior and improve the spatial learning and memory ability. RRP significantly reduced neuronal loss and increased the number of hippocampal stem cells, and promoted synaptic plasticity. In addition, FGF/FGFR signaling was upregulated after RRP treatment.

Conclusion: RRP can effectively reduce impulsive and spontaneous behavior and ameliorate hippocampal neurodevelopmental abnormalities in ADHD rat model.

References
1.
Sagvolden T . Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev. 2000; 24(1):31-9. DOI: 10.1016/s0149-7634(99)00058-5. View

2.
Grosso C, Santos M, Barroso M . From Plants to Psycho-Neurology: Unravelling the Therapeutic Benefits of Bioactive Compounds in Brain Disorders. Antioxidants (Basel). 2023; 12(8). PMC: 10451187. DOI: 10.3390/antiox12081603. View

3.
de Santana Souza L, de Siqueira P, Fernandes A, Martins R, Kubrusly R, Paes-de-Carvalho R . Role of Neuropeptide S on Behavioural and Neurochemical Changes of an Animal Model of Attention-Deficit/Hyperactivity Disorder. Neuroscience. 2020; 448:140-148. DOI: 10.1016/j.neuroscience.2020.09.030. View

4.
Andersen P, Egeland J, Oie M . Learning and memory impairments in children and adolescents with attention-deficit/hyperactivity disorder. J Learn Disabil. 2012; 46(5):453-60. DOI: 10.1177/0022219412437040. View

5.
Walsh R, Cummins R . The Open-Field Test: a critical review. Psychol Bull. 1976; 83(3):482-504. View